Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2005-12-27
2005-12-27
Chan, Christina (Department: 1644)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007240, C435S395000, C435S402000, C530S387100, C530S387300, C530S388220, C530S389600, C530S391100, C530S391300, C530S809000
Reexamination Certificate
active
06979546
ABSTRACT:
The invention relates to a novel compound termed NKp30 that is selectively expressed by all mature NK cells and that is involved in human natural cytoxicity as an activatory receptor, to new antibodies that bind to the NKp30 structure, and to the pharmaceutical and medicinal uses thereof.
REFERENCES:
patent: 5530101 (1996-06-01), Queen et al.
patent: WO 95/06247 (1995-03-01), None
patent: WO 99/23867 (1999-05-01), None
Harlow et al, in Antibodies a Laboratory Manual, 1988, Cold Spring harbor laboratory publication, Cold Spring Harbor, NY, pp. 92-94, pp. 116-117, 359-367, and 390-398.
Campbell et al, in Monoclonal Antibody Technology, 1984, Elsevier Science Publisher, New York, NY, p. 1-32.
Biassoni et al, Accession No. AJ223153 Sep. 1, 1999.
Ellison et al, J. Immunological Methods 186: 233-243; 1995.
Abaza et al, J of Protein Chemistry 11(5): 433-444, 1992.
Ngo et al., 1994, The Protein Folding Problem and Tertiary Structure Prediction, pp. 492-495.
Kuby et al, 1994, Immunology, Second edition, pp. 86-96.
Nalabolu et al., 1996, Genomics 31 :215-222.
Moretta, A., Cell, 1997, Jul. 11; 90(1) :13-8.
Genbank Nov. 1997, 1C7 sequence, accession No. AF 031138.
Sivori, S. et al., J. Exp. Med. Oct. 6, 1997; 186(7) :1129-36.
Moretta, A. et al., Eur. J. Immunogenet. Dec. 1997; 24(6) :455-68.
Moretta, A., et al., Curr. Top Microbiol. Immunol. 1998; 230 :15-23.
Vitale, M., et al., J. Exp. Med. Jun. 15, 1998; 187(12) :2065-72.
Poccia, F. et al., Immunol. Today, Jun. 1998; 19(6) :253-6.
Pessino, A., et al., J. Exp. Med., Sep. 7, 1998; 188(5) :953-60.
Cantoni, C., et al., J. Exp. Med. Mar. 1, 1999; 189(5) :787-96.
Biassoni, R. et al., Eur. J. Immunol., Mar. 1999; 29(3) :1014-20.
Biassoni, R. et al., Semin. Cancer Biol., Feb. 1999; 9(1) :13-8.
Sivori, S. et al., Eur. J. Immunol., May 1999; 29(5) :1656-66.
Falco, M. et al., Immunol. Lett., Jun. 1, 1999; 68(2-3) :411-4.
Neville, M.J. and Campbell, R.D., 1999, J. Immunol. 162 :4745-4754.
Moretta, A. et al., Curr. Top. Microbiol. Imunol., 1999; 244 :69-84.
Genbank disclosure on AJ 223153 sequence.
Ngo et al, in The Protein Folding Problem and Tertiary Structure . . . , 1994, Merz et al (ed.), Birkhauser, Boston, MA, pp. 433 and 492-495.
Skolnick et al, From genes to protein structure and function: novel applications . . . , Jan. 2000, Trends in Biotech. 18(1):34-39.
Attwood et al, The babel of bioinformatics, Oct. 2000, Science 290 (5491):471-473.
Mikayama et al, Molecular cloning and functional expression of cDNA . . . , Nov. 1993, Proc. Natl. Acad. Sci., USA, vol. 90: 10056-10060.
Voet et al, Biochemistry I, 1990, pp. 126-234.
Kuby et al, 1994, Immunology, Second edition, pp. 85-96.
Colman et al, Effects of amino acid sequence changes . . . , 1994, A structural view of immune recognition by antibodies, pp. 33-36.
Nalabolu et al, Accession 014932, Jan. 1998.
Biassoni et al. “Homo sapiens mRNA for activating NK-A1 receptor” XP-002167564 EMBL Accession No. AJ223153 (1999).
Cantoni et al. “NKp44, a triggering receptor involved in tumor cells lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily” XP-002167574 J. Exp. Med. 189:787-795 (1999).
Nalabolu et al. “1C7 precursor” XP-002167565 SwissPROT Accession No. 014932 (1998).
Nalabolu et al. “Genes in a 220-kb region spanning the TNF cluster in human MHC” XP-002101698 Genomics 31:215-222 (1996).
Pende et al. “Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells” XP-002167575 J. Exp. Med. 190:1505-1516 (1999).
Pessino et al, “Molecular cloning of NKp46: A novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity” XP-000953037 J. Exp. Med. 188:953-960 (1998).
Utans et al, “Allograft inflammatory factor-1” XP-002073637 Transplantation 61:1387-1392 (1996).
International Search Report for PCT/EP00/11697 dated Jun. 25, 2001.
Biassoni Roberto
Bottino Cristina
Moretta Alessandro
Chan Christina
Huynh Phuong
Innate Pharma S.A.S.
Saliwanchik Lloyd & Saliwanchik
Universita di Genova
LandOfFree
Triggering receptor involved in natural cytotoxicity... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triggering receptor involved in natural cytotoxicity..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triggering receptor involved in natural cytotoxicity... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3465797